Kalkine has a fully transformed New Avatar.

small-cap

What is mending between Capilano Honey and Bega Cheese?

Sep 05, 2018 | Team Kalkine
What is mending between Capilano Honey and Bega Cheese?

 

Capilano Honey


Mixed Updates: Capilano Honey Limited’s (ASX: CZZ) stock edged a bit low on September 04, 2018 while the honey industry is under the scanner as Capilano Honey’s Allowrie branded Mixed Blossom Honey is being stated to be adulterated in tests conducted in a German lab. CZZ is not the only player under the investigation, as IGA and Aldi have also been under the radar for the honey sold under different label brands. On the other hand, the company has recently strongly responded to the media and refused any concerns with its products mix and criticized the type of test used to detect the impurities.Further, the management stated that the company stands by its Allowrie honey as being 100% pure honey and the they do test on every batch.

Meanwhile, the group accepted to sell about 2% issued shares to Bega Cheese. Primarily, Bega Cheese Limited and its controlled entities bought 255,291 Capilano shares at an average price of $21.08 per share and hold 5.76% voting power in the company. Bega Cheese is now emerging to be one entity that is gaining interest on CZZ.

On the other hand, the group has entered into a Scheme Implementation Agreement with Bravo HoldCo Pty Ltd, under which is it proposed that a subsidiary of HoldCo will acquire 100% of the share capital of Capilano by way of a Scheme of Arrangement. If the Scheme is implemented then the Capilano’s shareholders will be entitled to $20.06 per share cash, which represents a premium of 28.2% to the last close of $15.65 per share and implies an FY18 P/E multiple of 19.3x and an EV / FY18 EBITDA multiple of 12.5x. The Scheme vote is proposed to be held in November 2018, with the Scheme execution proposed to happen in December 2018.


Financial Highlights (Source: Company Reports)

Meanwhile, the stock has risen 24.6 percent in the past three months as of September 03, 2018 and traded close to 52-week higher level. Based on foregoing, we maintain our “Hold” recommendation on the stock at the current market price of $21.01 while the group’s AGM is to be held in November and the story around takeover is still unfolding.
 


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.